SEC Form D filing

Cue Biopharma, Inc.

Biotech · Series B · Regulation D 506(b) · MA · Filed May 14, 2026

Offering amount
$30.0M
Exemption
Reg D 506(b)
Issuer state
MA
Filing date
May 14, 2026
Signature date
—
CIK
0001645460

Summary

$30M Cue Biopharma immunotherapy clear biotech in series-b range; established clinical-stage company.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.